BioAtla
BCAB
BCAB
67 hedge funds and large institutions have $14.2M invested in BioAtla in 2024 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 16 increasing their positions, 19 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
16% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 19
53% less capital invested
Capital invested by funds: $30.4M → $14.2M (-$16.2M)
Holders
67
Holding in Top 10
–
Calls
$84K
Puts
$34K
Top Buyers
| 1 | +$2.72M | |
| 2 | +$1.48M | |
| 3 | +$383K | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$296K |
| 5 |
Renaissance Technologies
New York
|
+$188K |
Top Sellers
| 1 | -$4.43M | |
| 2 | -$925K | |
| 3 | -$902K | |
| 4 |
Morgan Stanley
New York
|
-$446K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$309K |